• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Dendritic Cell/Myeloma Hybrid Vaccine

        互联网

        753
        Dendritic cell (DC)—tumor fusion hybrid vaccine that facilitates antigen presentation represents a new, powerful strategy in cancer therapy. We investigated the antitumor immunity derived from vaccination of fusion hybrids between wild-type J558 or engineered J558-IL-4 myeloma cells secreting cytokine interleukin-4 (IL-4) and DCs. The design and methods for generation of mature bone marrow-derived DCs, preparation of DC/J558-IL-4 hybrid, and in vivo animal studies of DC/myeloma hybrid vaccine are described. Our data show that the fusion efficiency was approx 20% by using polyethylene glycol. Our data also show that immunization of C57BL/6 mice with engineered DC/J558-IL-4 hybrids elicited stronger J558 tumor-specific cytotoxic T-lymphocyte responses in vitro and induced more efficient protective immunity against J558 tumor challenge in vivo than DC/J558 hybrid vaccines.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序